Related references
Note: Only part of the references are listed.TAp63 Prevents Premature Aging by Promoting Adult Stem Cell Maintenance
Xiaohua Su et al.
CELL STEM CELL (2009)
Phosphorylation and stabilization of TAp63γ by IκB kinase-β
Mary MacPartlin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of the bone
Cheng-Han Lee et al.
MODERN PATHOLOGY (2008)
Biochemical and structural studies of ASPP proteins reveal differential binding to p53, p63, and p73
Ross Alexander Robinson et al.
STRUCTURE (2008)
SCFβTrCP1 activates and ubiquitylates TAp63γ
Jayme R. Gallegos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A p53-derived apoptotic peptide derepresses p73 to cause tumor regression in vivo
Helen S. Bell et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
CHD5 is a tumor suppressor at human 1p36
Anindya Bagchi et al.
CELL (2007)
Restoration of p53 function leads to tumour regression in vivo
Andrea Ventura et al.
NATURE (2007)
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Wen Xue et al.
NATURE (2007)
p63 protects the female germ line during meiotic arrest
Eun-Kyung Suh et al.
NATURE (2006)
p63 heterozygous mutant mice are not prone to spontaneous or chemically induced tumors
William M. Keyes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis
JW Rocco et al.
CANCER CELL (2006)
Probing tumor phenotypes using stable and regulated synthetic microRNA precursors
RA Dickins et al.
NATURE GENETICS (2005)
p63 deficiency activates a program of cellular senescence and leads to accelerated aging
WM Keyes et al.
GENES & DEVELOPMENT (2005)
TAp63α induces apoptosis by activating signaling via death receptors and mitochondria
O Gressner et al.
EMBO JOURNAL (2005)
The ΔNp63α phosphoprotein binds the p21 and 14-3-3σ promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations
MD Westfall et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human
D Bergamaschi et al.
NATURE GENETICS (2003)
A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism
Z Serber et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
ΔNp63 induces β-catenin nuclear accumulation and signaling
M Patturajan et al.
CANCER CELL (2002)
Oncogenic ras and p53 cooperate to induce cellular senescence
G Ferbeyre et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Target gene specificity of E2F and pocket protein family members in living cells
J Wells et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
AIS is an oncogene amplified in squamous cell carcinoma
K Hibi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
